ACP-105 CAS 899821-23-9

  • WINGROUP
Attention:

Product  NameACP-105
SynonymsACP105;ACP  105;APC-105;Benzonitrile,  2-chloro-4-[(3-endo)-3-hydroxy-3-methyl-8-azabicyclo[3.2.1]oct-8-yl]-3-methyl-;ACP-105  fandachem
CAS NO899821-23-9
Molecular FormulaC16H19ClN2O
Molecular Weight290.79
Melting point 160 C
Boiling Point479.845.0 C(Predicted)
Flash PointN/M
Density 1.280.1 g/cm3(Predicted)
Purity99%
GradePharmaceutical Grade
SolubilityChloroform (Slightly), Ethyl  Acetate (Slightly), Methanol (Slightly)
AppearanceWhite Powder
StorageStore at dry and cool place
Packing and ShippingPacking: Drum / Aluminum Foil  Bag / According to customer's requiement                                                           Shipping: 3-5 working days after receive payment,  by Fedex,UPS,EMS,DHL,Sea and air transport
UsageIt is a powerful non-steroidal  bodybuilding supplement used to increase muscle mass and reduce body fat


ACP105 (899821-23-9) Description

ACP105.This SARM is a partial agonize which was primarily created as a potential treatment for bone degenerative disorders like osteoporosis and known for its highly powerful efficiency in promoting an increase in muscle mass.ACP105 is one of the best potent and yet safest means to help you gain lean muscle, endurance and strength.And what makes ACP105 stand out is the lack of harmful side effects.


ACP105 (899821-23-9) Mechanism of Action

ACP105, like other SARMs work by mimicking the role of the androgen -testosterone.

lt selectively binds with the androgen receptors (AR), working uniquely on each one of them.This ensures that it only does the necessary work and does not cause damage to vital organs and functions.

ACP 105 reduces the High Density Lipoprotein while increasing the fat free mass.This is how you grow muscles but don't get obese. Lack of amortization ensures there is no elevation in estrogen levels, hence no water retention.

It interferes with the negative feedback loop of the Hypothalamus - Pituitary axis.This results in an increase in testosterone level.This is why using SARMs for longer periods disrupt the hormonal balance and causes a testosterone suppression.A PCT corrects this easily,

Thus,ACP105 does the necessary work. You have achieved muscle growth while maintaining a healthy weight. Your body looks shredded, fit and healthy.


ACP105 (899821-23-9) Application

ACP105 urges the body to get rid of the abnormal fat

Our body has three types of fats, namely,.reserve fat,structural fat and the abnormal fat. The latter is unhealthy.ACP105 works in such a way that this stubborn fat gets utilized and burnt.


Prevents muscle wasting and promotes muscle growth

This property is what makes it as suitable product for possibly curing osteoporosis and other bone disorders.


Helps in quick recovery from injuries and exhaustion

ACP 105 provides your body with immense energy and stamina.Meaning you have longer endurance and hence can workout for extra hours without getting tired


Greatly enhances memory and cognitive skills

By increasing the levels of Androgenic Receptors (AR) in the hippocampus region.


ACP105 (899821-23-9) Side Effects & Warning

A mild headache.ACP105 usually occurs when you first begin using the product.As soon as your body gets used to the drug it stops.

Little suppression in the testosterone levels.This usually begins from 7th or 8th week of use.This is when you need to stop the cycle and go for a Post Cycle Therapy(PCT)

. You may experience fatigue and nausea.

. User may feel exhausted quicker in the 7th or 8th week.


Reference

1. Mooradian AD, Morley JE, Korenman SG. Biological actions of androgens. Endocr Rev. 1987;8(1):1-28.

2. Mangelsdorf DJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: the second decade. Cell. 1995;83(6):835-839.

3. Sar M, Lubahn DB, French FS, Wilson EM. Immuno-histochemical localization of the androgen receptor in rat and human tissues. Endocrinology. 1990;127(6):3180-3186.

4. Gao W, Bohl CE, Dalton JT. Chemistry and structural biology of androgen receptor. Chem Rev. 2005;105(9):3352-3370.

5.Heinlein CA, Chang C. Androgen receptor in prostate cancer. Endocr Rev. 2004;25(2):276-308.



WELCOME TO WINGROUP PHARMACEUTICAL

We sincerely welcome friends from all walks of life at home and abroad to visit us and cooperate with us sincerely

CATALOG

CONTACT

+86-27-87819568
CELLPHONE:+86-18062075862

admin@whwingroup.com
Copyright 2020-2035 All rights reserved